Citation Impact
Citing Papers
Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice Guideline
2008 Standout
Dry Eye Disease Treatment: A Systematic Review of Published Trials and a Critical Appraisal of Therapeutic Strategies
2013
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Tadalafil Therapy for Pulmonary Arterial Hypertension
2009 Standout
Expected characteristics of an ideal, all-purpose inhaled corticosteroid for the treatment of asthma
2003
A comparison of the efficacy and safety of inhaled corticosteroids in asthma
1997
Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens
2006 Standout
Nucleotide signalling during inflammation
2014 StandoutNature
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Final Report of the Lyme Disease Review Panel of the Infectious Diseases Society of America
2010
Effect of the platelet‐activating factor antagonist, TCV‐309, and the cyclo‐oxygenase inhibitor, ibuprofen, on the haemodynamic changes in canine experimental endotoxic shock
1993 StandoutNobel
Global Initiative for Chronic Obstructive Lung Disease
2002 Standout
Marine natural products
1990 Standout
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Interpretation of Changes in Health-related Quality of Life
2003 Standout
Oral Glucocorticoid-Sparing Effect of Mepolizumab in Eosinophilic Asthma
2014 Standout
Extracellular Adenosine Triphosphate and Chronic Obstructive Pulmonary Disease
2010
Variability of symptoms in mild persistent asthma: baseline data from the MIAMI study
2004
Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review
2004
Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial
2000
Quality of life during formoterol treatment: comparison between asthma-specific and generic questionnaires. Canadian and the Dutch Formoterol Investigators
1998
A New Equation to Estimate Glomerular Filtration Rate
2009 Standout
Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease
1999 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Inhaled and nasal corticosteroids Factors affecting the risks of systemic adverse effects
1999
Comparative responsiveness of generic and specific quality-of-life instruments
2003
Systemic Adverse Effects of Inhaled Corticosteroid Therapy
1999
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
2015 Standout
Diagnosis and Complications of Cushing’s Syndrome: A Consensus Statement
2003 Standout
Development and first validation of the COPD Assessment Test
2009 Standout
DIAGNOSIS AND MANAGEMENT OF STEROID-RESISTANT ASTHMA
1997
Conventional Therapy of Sjogren’s Syndrome
2007
Phase 2 Randomized Safety and Efficacy Trial of Nebulized Denufosol Tetrasodium in Cystic Fibrosis
2007
Fluticasone at different doses for chronic asthma in adults and children
2005
P2X 7 Receptor Signaling in the Pathogenesis of Smoke-Induced Lung Inflammation and Emphysema
2010
Advair: Combination treatment with fluticasone propionate/salmeterol in the treatment of asthma
2001
Mechanisms of drug combinations: interaction and network perspectives
2009 Standout
Synthetic approaches to the 2010 new drugs
2012
Physiology and Pathophysiology of Purinergic Neurotransmission
2007 Standout
Quality of life changes in COPD patients treated with salmeterol.
1997
α-Adrenoceptors
1994
Potential Effects of Fluticasone Propionate on Bone Mineral Density in Patients With Asthma: A 2-Year Randomized, Double-Blind, Placebo-Controlled Trial
2004
β-Adrenergic Receptor Kinase-1 Levels in Catecholamine-Induced Myocardial Hypertrophy
1999 StandoutNobel
SF-36 Health Survey Update
2000 Standout
Global strategy for asthma management and prevention: GINA executive summary
2007 Standout
Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7)
2005 Standout
Sildenafil Improves Health-Related Quality of Life in Patients With Pulmonary Arterial Hypertension*
2008
Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease
2007 Standout
International Union of Pharmacology LVIII: Update on the P2Y G Protein-Coupled Nucleotide Receptors: From Molecular Mechanisms and Pathophysiology to Therapy
2006
Glucocorticoid-induced osteoporosis
2000
Risk-Benefit Assessment of Fluticasone Propionate in the Treatment of Asthma and Allergic Rhinitis
1998
Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma
2000
Lyme borreliosis
2011 Standout
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
2002 Standout
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Pharmacological profiles of cloned mammalian P2Y-receptor subtypes
2005
A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease
2008 Standout
Long term effects of denufosol tetrasodium in patients with cystic fibrosis
2012
Asthma
2000 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Effect of Exacerbation on Quality of Life in Patients with Chronic Obstructive Pulmonary Disease
1998 Standout
Severe Asthma in Adults
2005
Can Guideline-defined Asthma Control Be Achieved?
2004
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease
2016 StandoutNobel
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children
2004
New Iantherans from the Marine Sponge Ianthella quadrangulata: Novel Agonists of the P2Y11 Receptor
2007
Beclomethasone for asthma in children: effects on linear growth
1999
Purinergic Receptor Inhibition Prevents the Development of Smoke-Induced Lung Injury and Emphysema
2010
Peripheral adrenergic receptors in hypertension.
1990
Primary Aldosteronism
1988
DAMP-sensing receptors in sterile inflammation and inflammatory diseases
2019 Standout
Preferential venoconstriction by cyclooxygenase inhibition in vivo without attenuation of nitroglycerin venodilation.
1988
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
The Management of Primary Aldosteronism: Case Detection, Diagnosis, and Treatment: An Endocrine Society Clinical Practice Guideline
2016 Standout
Fluticasone at different doses for chronic asthma in adults and children
2008
Canadian Thoracic Society Recommendations for Management of Chronic Obstructive Pulmonary Disease – 2007 Update
2007
Serum Creatinine as an Index of Renal Function: New Insights into Old Concepts
1992 Standout
Relative Efficacy of Vasodilator Therapy in Chronic Congestive Heart Failure
1988
Use of Inhaled Corticosteroids and Risk of Fractures
2001 Standout
An Evaluation of Nebulized Levalbuterol in Stable COPD
2003
Natural Products as Sources of New Drugs from 1981 to 2014
2016 Standout
Catalytic Asymmetric Transacetalization
2010 StandoutNobel
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
1998 StandoutNobel
Direct Catalytic Asymmetric Synthesis of Cyclic Aminals from Aldehydes
2008 StandoutNobel
National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification
2003 Standout
Industry sponsorship and research outcome
2017 Standout
Lys49 myotoxin from the Brazilian lancehead pit viper elicits pain through regulated ATP release
2017 StandoutNobel
Physiology of Microglia
2011 Standout
Drug Prescribing in Renal Failure: Dosing Guidelines for Adults.
1988
Works of Donald J. Kellerman being referenced
Pharmacokinetics and Pharmacodynamics of Cumulative Single Doses of Inhaled Salbutamol Enantiomers in Asthmatic Subjects
1999
A 12-Week Dose-Ranging Study of Fluticasone Propionate Powder in the Treatment of Asthma
1996
Diquafosol tetrasodium: a novel dry eye therapy
2004
Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life.
1995
Denufosol: A review of studies with inhaled P2Y2 agonists that led to Phase 3
2008
Double-Masked, Placebo-Controlled Safety and Efficacy Trial of Diquafosol Tetrasodium (INS365) Ophthalmic Solution for the Treatment of Dry Eye
2004
Dose-Related Response to Inhaled Fluticasone Propionate in Patients with Methacholine-Induced Bronchial Hyperresponsiveness: A Double-Blind, Placebo-Controlled Study
1998
Fluticasone propionate powder and lack of clinically significant effects on hypothalamic-pituitary-adrenal axis and bone mineral density over 2 years in adults with mild asthma
1999
Comparative Efficacy and Safety of Twice Daily Fluticasone Propionate Powder Versus Placebo in the Treatment of Moderate Asthma
1997
Fluticasone Propionate Improves Quality of Life in Patients with Asthma Requiring Oral Corticosteroids
1996
Efficacy of Inhaled Fluticasone Propionate in Asthma Results from Topical and Not from Systemic Activity
1997
Prazosin Update A Review of its Pharmacological Properties and Therapeutic Use in Hypertension and Congestive Heart Failure
1983
Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris.
1983
47 Denufosol tetrasodium inhalation solution: results from two phase 2 trials in CF patients with mild to moderate lung disease
2006